AMR / France: Becoming a European Vaccination Leader?
France is home to the highest rates of vaccine mistrust in Europe, with a third of French people disagreeing that…
France
Coronavirus / France’s Institut Pasteur; On Course to Develop a Vaccine?
Researchers at the Institut Pasteur in Paris have become the first in Europe to fully sequence the genome of the 2019-nCoV coronavirus - putting the Institut at the forefront of…
Internationalization / France's Mid-Cap Pharma Champions Look to Global Markets
With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma…
AI / France's Quest for Life Sciences 4.0
With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on…
In Conversation
Éric Ducournau – CEO, Pierre Fabre Group
Éric Ducournau, global CEO of Pierre Fabre Group, the second largest dermo-cosmetic company worldwide and the third-largest French pharmaceutical laboratory, provides insights into the group’s on-going internationalization and its emerging markets strategy, while reaffirming Pierre Fabre’s commitment to France’s healthcare innovation ecosystem. As illustrated by the group’s new motto ‘Taking Care, Living Better’, Ducournau also highlights the ever-growing convergence of…
France Pharma Snapshot 2019
A snapshot of the latest data on the French pharmaceutical industry from industry association LEEM, including…
Related Report
New France Pharma Report June 2019 Out Now
The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a…
Coronavirus / France’s Institut Pasteur; On Course to Develop a Vaccine?
Researchers at the Institut Pasteur in Paris have become the first in Europe to fully sequence the genome of the…
Ipsen / Problems Pile Up after Further Clinical Setback
These are worrying times for iconic French mid-cap Ipsen. Trials for palovarotene, a treatment for rare bone…
Top Causes of Death in France
Cancer is the leading cause of death in France, accounting for 28.5% of all deaths in 2014, followed by…
Cell & Gene Therapy / Finding the Funding in France
France – one of the most influential countries in the development of gene therapy– still stands as a global…
AMR / France: Becoming a European Vaccination Leader?
France is home to the highest rates of vaccine mistrust in Europe, with a third of French people disagreeing that…
Government Sector Organisations: France
The healthcare and life sciences industries, as they become more advanced and complex, increasingly require…
Brexit: A Window of Opportunity for France’s Drug Regulator?
As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…
AstraZeneca’s EUR 135 Million Investment in France
On January 21st, 2019, AstraZeneca inaugurated the extension of the group’s industrial site in the city of…
AI / France's Quest for Life Sciences 4.0
With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on…